• 45 Investors
  • COVID-19 MedTech Industry Landscape by Sector
1. AIM ImmunoTech 1990
2. Altimmune 1997
3. Applied DNA Sciences 1983
4. Arcturus Therapeutics 2013
5. Athersys 1995
6. BGI Genomics 1999
7. Brii Biosciences 2018
8. Butterfly Network 2011
9. Capricor Therapeutics 2005
10. Cipla 1935
11. Cocrystal Pharma 2004
12. Duke University
13. Eli Lilly
14. Emergent BioSolutions 1998
15. Enanta Pharmaceuticals 1998
16. Fosun Pharma 1994
17. Generex Biotechnology 1983
18. Grifols 1940
19. Hospital Israelita Albert Einstein 1
20. Hoth Therapeutics 2017
21. Innovation Pharmaceuticals 2007
22. Inovio Pharmaceuticals 1979
23. Israel Aerospace Industries 1953
24. LabCorp 1978
25. Lattice Biologics 2013
26. Moderna 2010
27. Neurimmune Holding 2006
28. Novan 2008
29. PerkinElmer 1931
30. Pharmstandard 2003
31. Q BioMed 2013
32. Roche Holding AG
33. Roivant Sciences 2014
34. Sorrento Therapeutics 2006
35. Teva Pharmaceuticals 0
36. University of Birmingham 1900
37. University of California 1868
38. University of Chicago 1890
39. University of Melbourne 1853
40. University of Minnesota
41. University of Pennsylvania
42. University of Zurich 1833
43. Washington University in St. Louis 1853
44. Windtree Therapeutics 1992
45. Yale University 1701

«COVID-19 MedTech Industry Landscape by Sector»

  • — investor and funding support bodies
  • — hubs and other organisation types

Industries

AI
Aerospace, Infrastructure, Manufacturing, Military, National Security, Navigation
Big Data, Business Development, Education, Universities
Biotechnology
Biotechnology, Data and Analytics, Health Care, Science and Engineering
Biotechnology, Health Care, Professional Services, Science and Engineering
Communities, Education, Systemic, Training, Universities
E-Learning, EBooks, Education, Higher Education
E-Learning, Education, Higher Education, Legal
FemTech
Investment Funds
Investor
Longevity
R&D Centre
SciTech
test_custom_domain_2
© 2026